Extracellular Matrix News Volume 1.32 | Dec 16 2010

    0
    24
    Extracellular Matrix News 1.32, December 16, 2010.  
    In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  EventsSubscribe  |  Unsubscribe

    TOP STORY

    Degradable Polyester Scaffolds with Controlled Surface Chemistry Combining Minimal Protein Adsorption with Specific Bioactivation  ShareThis
    Researchers present a one-step preparation of fully synthetic, bioactive and degradable extracellular matrix-mimetic scaffolds by electrospinning, using poly(D,L-lactide-co-glycolide) as the matrix polymer. [Nat Mater]

    mFreSRSample_645x110_v01


    SPECIAL FEATURE

    Interested in recruiting talented individuals? Post your career opportunities in Extracellular Matrix News at no cost. Contact us at info@connexoncreative.com

    Twitter Follow us on Twitter! @ExtracellMatrix


    SCIENCE NEWS

    Cells ‘Feel’ the Difference Between Stiff or Soft and Thick or Thin Matrix
    Cultured mesenchymal stem cells can “feel” at least several microns below the surface of an artificial microfilm matrix, gauging the elasticity of the extracellular bedding that is a crucial variable in determining their fate. [Press release from EurekAlert! discussing research presented at American Society of Cell Biology 50th Annual Meeting]

    EasySep_645x110_v01


    CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

    Lineage Restriction of Human Hepatic Stem Cells to Mature Fates Is Made Efficient by Tissue-Specific Biomatrix Scaffolds
    Biomatrix scaffolds can be used for biological and pharmaceutical studies of lineage-restricted stem cells, for maintenance of mature cells, and, in the future, for implantable, vascularized engineered tissues or organs. [Hepatology]

    Maturational Growth of Self-Assembled, Functional Menisci as a Result of TGF-Beta1 and Enzymatic Chondroitinase-ABC Stimulation
    In an effort to obtain the geometric properties and the maturational growth necessary for the recapitulation of biochemical and, thus, biomechanical properties, a scaffoldless cell-based system, the self-assembly process, was used in conjunction with the catabolic enzyme chondroitinase-ABC and TGF-beta1. [Biomaterials ]

    Bioactivation of Dermal Scaffolds with a Non-Viral Copolymer-Protected Gene Vector
    Researchers activated an FDA-approved collagen scaffold for dermal regeneration by incorporation of copolymer-protected gene vectors to induce a temporary release of VEGF. [Biomaterials]

    Distinct Roles for Paxillin and Hic-5 in Regulating Breast Cancer Cell Morphology, Invasion and Metastasis
    Researchers show that the focal adhesion adaptor protein, Paxillin and the closely related Hic-5, have distinct and unique roles in the regulation of breast cancer cell lung metastasis by modulating cell morphology and cell invasion through three dimensional extracellular matrices. [Mol Biol Cell]

    Integrin-Linked Kinase Is Required for TGF-Beta1 Induction of Dermal Myofibroblast Differentiation
    Researchers conclude that integrin-linked kinase is necessary to transduce signals implicated in the transition of dermal fibroblasts to myofibroblasts originating from matrix substrates and TGF-Beta1. [J Invest Dermatol]
     
    Promoting External Inosculation of Prevascularized Tissue Constructs by Pre-Cultivation in an Angiogenic Extracellular Matrix
    The engineering of preformed microvessels offers the promising opportunity to rapidly vascularize implanted tissue constructs by the process of inosculation. Herein, researchers analyzed whether this process may further be accelerated by cultivation of prevascularized tissue constructs in Matrigel before implantation. [Eur Cell Mater]

    Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 Is Necessary for Normal Endochondral Ossification and Aggrecan Metabolism
    Observations suggest that chondroitin sulfate N-acetylgalactosaminyltransfease 1 is necessary for normal levels of endochondral ossification and the decrease in chondroitin sulfate amount in the growth plate by its absence causes a rapid catabolism of aggrecan. [J Biol Chem]

    Role of Integrins in Angiotensin II-Induced Proliferation of Vascular Smooth Muscle Cells
    To study crosstalk between GPCR- and integrin-induced signaling, researchers hypothesized that integrins are involved in AII-induced proliferation of vascular smooth muscle cells. [Am J Physiol Cell Physiol]

    Labeling of Fibronectin by Fluorescent and Paramagnetic Nanoprobes for Exploring the Extracellular Matrix: Bioconjugate Synthesis Optimization and Biochemical Characterization
    The local structure and global conformation of fibronectin-nanoparticle bioconjugates were studied by fluorescence spectroscopy and enzymatic sites accessibility. [Anal Bioanal Chem]

    Influence of Glial-Derived Matrix Molecules, Especially Chondroitin Sulfates, on Neurite Growth and Survival of Cultured Mouse Embryonic Motoneurons
    Results indicate that molecules of the extracellular matrix, especially chondroitin sulfates, play an important role as axon growth-promoting cues. [J Neurosci Res]
     
    Novel Tissue-Derived Biomimetic Scaffold for Regenerating the Human Nucleus Pulposus
    In the present study, researchers describe a novel approach to develop a tissue engineering scaffold comprised acellular porcine nucleus pulposus extracellular matrix. [J Biomed Mater Res A]


    INDUSTRY NEWS

    Establishment of Olympus Biotech, and Its Acquisition of Osteogenic Protein-1 (OP-1) Assets from U.S.-Based Stryker Biotech
    Olympus Corporation announced the establishment of a new company, Olympus Biotech Corporation in the United States. Agreement has been reached with Stryker Corporation concerning Olympus Biotech’s acquisition from Stryker Biotech of a majority of assets in the bone field pertaining to the development, manufacture and sale of Osteogenic Protein-1. [Olympus Corporation Press Release] 

    Harvard Bioscience Files Two Major Patents in Field of Regenerative Medicine
    Harvard Bioscience, Inc. has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth. [Harvard Bioscience, Inc. Press Release]

    First Patient Enrolled in Multi-Center Clinical Trial of the CorMatrix® ECM® for Pericardial Closure to Reduce the Incidence of New Onset Postoperative Atrial Fibrillation
    CorMatrix Cardiovascular, Inc. announced that Franciscan Alliance/St. Francis Heart Center in Indianapolis, Indiana is the first site to enroll a patient in the multi-center clinical trial of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation. [PR Newswire]
     
    New Dermagraft Coding to Streamline Reimbursement Process for Medicare Providers
    Advanced BioHealing, Inc. announced the Centers for Medicare and Medicaid Services has assigned two new procedure codes for the application of Dermagraft®, effective January 1, 2011. [Advanced BioHealing, Inc. Press Release]

    Halozyme Announces Roche Completes Patient Enrollment in Phase III Clinical Trial with Subcutaneous Herceptin®
    Halozyme Therapeutics, Inc. announced that Roche has completed patient enrollment for the pivotal Phase III study of Herceptin SC (trastuzumab subcutaneous), a subcutaneous formulation that uses Halozyme’s Enhanze™ technology (rHuPH20, recombinant human hyaluronidase). [Halozyme Therapeutics, Inc. Press Release]


    POLICY NEWS

    House Approves Flat 2011 Budget for Most Science Agencies
    The three federal agencies that support the vast majority of academic research would receive no more money in 2011 than in 2010 under a spending bill that narrowly passed the House of Representatives. [House of Representatives, United States]

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)


    EVENTS (Listed by Date)

    Pharmacology in Stem Cells Research and Regenerative Medicine
    December 17, 2010
    London, United Kingdom

    The 3rd Guangzhou International Conference on Stem Cell Biology and Regenerative Medicine
    December 17-19, 2010
    Guangzhou, China

    Keystone Symposia: Epithelial Plasticity and Epithelial to Mesenchymal Transition
    January 21-26, 2011
    Vancouver, Canada

    Extracellular Matrix and Cardiovascular Remodeling
    January 23-28, 2011
    Tahoe City, United States

    5th Annual Stem Cells and Regenerative Medicine World Congress
    January 24-25, 2011
    San Diego, United States

    BIO Asia International Partnering Conference
    January 24-25, 2011
    Tokyo, Japan

    Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
    January 24-26, 2011
    Washington, D.C., United States

    IQPC’s 4th Biobanking Conference
    January 24-26, 2011
    Philadelphia, United States

    AACR-ACS Joint Meeting on Chemistry in Cancer Research: The Biological Chemistry of Inflammation as a Cause of Cancer
    January 30-February 2, 2011
    San Diego, United States

    Molecular Medicine Tri-Conference: Stem Cells – Revolutionizing Regenerative Medicine and Personalized Therapy 2011
    February 23-25, 2011
    San Francisco, United States

    Cell Culture World Congress 2011 – Optimising Cell Culture Development for Biopharmaceutical, Bioprocessing and Manufacture
    February 28-March 2, 2011
    Munich, Germany

    PITTCON Conference & Expo 2011
    March 13-18, 2011
    Atlanta, United States

    15th Annual Hilton Head Workshop – Regenerative Medicine, Innovations for Clinical Applications
    March 16-19, 2011
    Hilton Head Island, United States

    United Kingdom National Stem Cell Network 2011 Annual Scientific Conference
    March 30-April 1, 2011
    York, United Kingdom

    World Stem Cells & Regenerative Medicine Congress 2011
    May 9-11, 2011
    London, United Kingdom

    13th Annual C21 BioVentures
    May 24-26, 2011
    Napa, United States

    Visit our events page  to stay up to date with the latest events in the cell, gene and immunotherapy community.


    JOB OPPORTUNITIES

    Lab Technologist – Cell Separation (STEMCELL Technologies)

    Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)

    Lab Technologist – Tissue Culture (STEMCELL Technologies)

    Recruit Top Talent

    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News at no cost.
    Visit
    here to post your career opportunities.


    Have we missed an important article or publication in Extracellular Matrix News? Click here to submit!

     

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.
     

    Learn more about Extracellular Matrix News: Archives  |  Events  |  Subscribe  |  Contact Us